These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28072830)

  • 1. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.
    QuanJun Y; GenJin Y; LiLi W; YongLong H; Yan H; Jie L; JinLu H; Jin L; Run G; Cheng G
    PLoS One; 2017; 12(1):e0169567. PubMed ID: 28072830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanin analog enhances the protective effect of dexrazoxane against doxorubicin-induced cardiotoxicity.
    Lue Y; Gao C; Swerdloff R; Hoang J; Avetisyan R; Jia Y; Rao M; Ren S; Atienza V; Yu J; Zhang Y; Chen M; Song Y; Wang Y; Wang C
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H634-H643. PubMed ID: 29775411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane.
    Della Torre P; Mazué G; Podestà A; Moneta D; Sammartini U; Imondi AR
    Cancer Chemother Pharmacol; 1999; 43(2):151-6. PubMed ID: 9923821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.
    Vijay V; Moland CL; Han T; Fuscoe JC; Lee T; Herman EH; Jenkins GR; Lewis SM; Cummings CA; Gao Y; Cao Z; Yu LR; Desai VG
    Toxicol Appl Pharmacol; 2016 Mar; 295():68-84. PubMed ID: 26873546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel.
    Della Torre P; Imondi AR; Bernardi C; Podestà A; Moneta D; Riflettuto M; Mazué G
    Cancer Chemother Pharmacol; 1999; 44(2):138-42. PubMed ID: 10412948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
    Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
    Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
    Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
    Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity.
    Liu H; Wang H; Xiang D; Guo W
    Mini Rev Med Chem; 2017; 17(1):44-50. PubMed ID: 27337969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats.
    Xu M; Sheng L; Zhu X; Zeng S; Chi D; Zhang GJ
    Tumori; 2010; 96(3):460-4. PubMed ID: 20845809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats.
    Al-Harbi NO
    Toxicol Mech Methods; 2016; 26(3):189-95. PubMed ID: 26899300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
    Swain SM; Whaley FS; Gerber MC; Weisberg S; York M; Spicer D; Jones SE; Wadler S; Desai A; Vogel C; Speyer J; Mittelman A; Reddy S; Pendergrass K; Velez-Garcia E; Ewer MS; Bianchine JR; Gams RA
    J Clin Oncol; 1997 Apr; 15(4):1318-32. PubMed ID: 9193323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the metabolic rewiring in the context of doxorubicin-induced cardiotoxicity: Fuel preference changes from fatty acids to glucose oxidation.
    Guerra G; Russo M; Priolo R; Riganti C; Reano S; Filigheddu N; Hirsch E; Ghigo A
    Vascul Pharmacol; 2024 Jun; 155():107324. PubMed ID: 38985581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats.
    Ammar el-SM; Said SA; Suddek GM; El-Damarawy SL
    Can J Physiol Pharmacol; 2011 Apr; 89(4):269-76. PubMed ID: 21526973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
    Lenčová-Popelová O; Jirkovský E; Jansová H; Jirkovská-Vávrová A; Vostatková-Tichotová L; Mazurová Y; Adamcová M; Chládek J; Hroch M; Pokorná Z; Geršl V; Šimůnek T; Štěrba M
    J Mol Cell Cardiol; 2016 Feb; 91():92-103. PubMed ID: 26724189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dexrazoxane and amifostine against late cardiotoxicity induced by the combination of doxorubicin and cyclophosphamide in vivo.
    Bjelogrlic SK; Lukic ST; Djuricic SM
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):228-38. PubMed ID: 23692343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats.
    Hu H; Xie C; Weng Z; Yu P; Wang Y; Shan L
    Pharmacology; 2022; 107(3-4):206-215. PubMed ID: 35021174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
    Koleini N; Kardami E
    Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.